The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of protein tyrosine phosphatase non-receptor 11 (PTPN11) mutations in lung squamous cell carcinoma (SQCC).
Yasir Elamin
No relevant relationships to disclose
Sinead Toomey
No relevant relationships to disclose
Aoife Carr
No relevant relationships to disclose
Kenneth O'Byrne
No relevant relationships to disclose
Shereen Rafee
No relevant relationships to disclose
Kathy Gately
No relevant relationships to disclose
Oscar S. Breathnach
No relevant relationships to disclose
Sinead Cuffe
No relevant relationships to disclose
William Grogan
No relevant relationships to disclose
Patrick Glyn Morris
No relevant relationships to disclose
Bryan Hennessy
No relevant relationships to disclose